Carlsmed (CARL) Net Cash Flow (2024 - 2026)

Carlsmed (CARL) has 3 years of Net Cash Flow data on file, last reported at -$12.8 million in Q1 2026.

• For the quarter ending Q1 2026, Net Cash Flow fell 486.36% year-over-year to -$12.8 million; the trailing twelve-month figure through Mar 2026 stood at $29.6 million (up 459.88% YoY), and the FY2025 full-year result was $45.7 million, up 39.01% from the prior year.
• Net Cash Flow for Q1 2026 stood at -$12.8 million, up from -$29.6 million in the prior quarter.
• Across five years, Net Cash Flow topped out at $81.9 million in Q3 2025 and bottomed at -$29.6 million in Q4 2025.
• The 3-year median for Net Cash Flow is -$4.3 million (2024), against an average of $5.0 million.
• Peak annual rise in Net Cash Flow reached 1201.67% in 2025, while the deepest fall reached 585.52% in 2025.
• A 3-year view of Net Cash Flow shows it stood at -$4.3 million in 2024, then slumped by 585.52% to -$29.6 million in 2025, then surged by 56.81% to -$12.8 million in 2026.
• The last three Net Cash Flow figures came in at -$12.8 million (Q1 2026), -$29.6 million (Q4 2025), and $81.9 million (Q3 2025), per Business Quant data.

Peer Comparison